Boston Scientific WATCHMAN FLX™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial ...Middle East

Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation MARLBOROUGH, Mass. and CHICAGO, Nov. 16, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced...

Read More Details
Finally We wish PressBee provided you with enough information of ( Boston Scientific WATCHMAN FLX™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial )

Also on site :

• Peter Weber Goes Public With His Relationship and His Family Has Thoughts
• ‘American Pickers’ Danielle Colby Makes Bold Declaration About Mike Wolfe Relationship
• Rachel Bilson Shares Rare Photo of Briar Rose, Her Daughter with Ex Hayden Christensen